Access cutting-edge leukemia treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access leukemia specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related leukemia treatment provided free
The goal of this clinical trial is to determine the safety and feasibility of allogeneic transplantation with bone marrow from a deceased donor in patients with acute and chronic leukemias, myelodysplastic syndrome, and certain lymphomas. Patients will either receive myeloablative conditioning or reduced intensity conditioning regimen prior to the transplant. Patients will be followed for 56 days for safety endpoints and remain in follow-up for one year.
Sponsor: Ossium Health, Inc.
Check if you qualify for this leukemia clinical trial in New York, NY
If you're searching for leukemia treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced leukemia specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.